BamSEC and AlphaSense Join Forces
Learn More

Arrowhead Pharmaceuticals Inc.

NASDAQ: ARWR    
Share price (12/20/24): $19.45    
Market cap (12/20/24): $2.420 billion
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.2
from 10-Q 4 pages Delaware the First State Page 1 3354811 8100 Authentication: 203227797 Sr# 20231665245 Date: 04-27-23 You May Verify This Certificate Online at CORP.DELAWARE.GOV/AUTHVER.SHTML I, Jeffrey W. Bullock, Secretary of State of the State of Delaware, Do Hereby Certify the Attached Is a True and Correct Copy of the Certificate of Amendment of “Arrowhead Pharmaceuticals, Inc.”, Filed in This Office on the Twenty- Seventh Day of April, A.D. 2023, at 10:05 O`clock A.M
12/34/56
EX-3.2
from 10-Q 16 pages Second Amended and Restated Bylaws of Arrowhead Pharmaceuticals, Inc
12/34/56
EX-3.1
from 10-Q 14 pages Amended and Restated Certificate of Incorporation of Arrowhead Research Corporation
12/34/56
EX-3.1
from 8-K 19 pages Articles of Incorporation or Bylaws
12/34/56
EX-3.1
from 8-K 8 pages Certificate of Designation, Preferences, and Rights of Series D Junior Participating Preferred Stock of Arrowhead Pharmaceuticals, Inc. Pursuant to Section 151 of the General Corporation Law of the State of Delaware
12/34/56
EX-3.4
from 8-K 10 pages Amended and Restated Bylaws of Arrowhead Pharmaceuticals, Inc
12/34/56
EX-3.3
from 8-K 15 pages Amended and Restated Certificate of Incorporation of Arrowhead Research Corporation
12/34/56
EX-3.2
from 8-K 2 pages Certificate of Elimination of Series B Convertible Preferred Stock of Arrowhead Research Corporation (Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware)
12/34/56
EX-3.1
from 8-K 2 pages Certificate of Elimination of Series a Convertible Preferred Stock of Arrowhead Research Corporation (Pursuant to Section 151(g) of the General Corporation Law of the State of Delaware)
12/34/56
EX-3.1
from 8-K 17 pages Form of Certificate of Designation Arrowhead Research Corporation Certificate of Designation of Preferences, Rights and Limitations of Series C Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law B-1 Terms of Preferred Stock
12/34/56
EX-3.1
from 8-K 18 pages Form of Certificate of Designation Arrowhead Research Corporation Certificate of Designation of Preferences, Rights and Limitations of Series B Convertible Preferred Stock Pursuant to Section 151 of the Delaware General Corporation Law -1- Terms of Preferred Stock
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment of Certificate of Incorporation of Arrowhead Research Corporation
12/34/56
EX-3.1
from 8-K 13 pages II. Certain Definitions
12/34/56
EX-3.1
from 8-K 6 pages Amendment No. 1 to the Bylaws of Arrowhead Research Corporation
12/34/56
EX-3.4
from 10-K 1 page Certificate of Amendment of Certificate of Incorporation of Arrowhead Research Corporation a Delaware Corporation
12/34/56
EX-3.4
from 10QSB 1 page Certificate of Amendment of Certificate of Incorporation of Arrowhead Research Corporation a Delaware Corporation
12/34/56